Apollo Endosurgery Inc RSI
Was ist das RSI von Apollo Endosurgery Inc?
RSI von Apollo Endosurgery Inc ist 66.09
Was ist die Definition von RSI?
Der relative Stärke-Index (RSI 14) ist ein Momentumindikator, der die Größe von Gewinnen und Verlusten über einen bestimmten Zeitraum vergleicht, um die Geschwindigkeit und die Änderung von Preisbewegungen eines Wertpapiers zu messen.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Apollo Endosurgery Inc
Was macht Apollo Endosurgery Inc?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Unternehmen mit rsi ähnlich Apollo Endosurgery Inc
- Nautilus Inc hat RSI von 66.06
- Koninklijke Philips N.V hat RSI von 66.07
- Filatex India hat RSI von 66.07
- 51Job hat RSI von 66.08
- Meituan Dianping hat RSI von 66.08
- Orbital hat RSI von 66.08
- Apollo Endosurgery Inc hat RSI von 66.09
- Social Capital Hedosophia III hat RSI von 66.10
- BroadVision hat RSI von 66.11
- Ester Industries hat RSI von 66.11
- Wereldhave Belgium SCA hat RSI von 66.11
- Source Stoxx Europe 600 Opt Con hat RSI von 66.12
- Wintrust hat RSI von 66.12